It was announced today that one of the world’s leading healthcare companies, GSK, has opened an €8 million investment project at its manufacturing site in Dungarvan. 

The facility was officially this morning by Site Director, Brian Fox. The investment has been utilised to develop a new purpose-built biomass energy facility which is expected to reduce the site’s carbon emissions by up to 33%. The facility uses locally sourced woodchips to create a carbon neutral fuel source for the site.

GSK, who this year celebrate 35 years in Dungarvan, employs over 700 employees at two sites in the area.

Today’s announcement follows two recent investments made by GSK in the Dungarvan facility. The organisation recently invested €8m in the implementation of a new environmentally friendly packaging line that utilises a 100% recyclable material called Polypropylene. This offers a sustainable solution for the production of ‘blister’ packaged products as it allows the entire blister pack to be manufactured from one recyclable material.
 
Furthermore, GSK also invested in a €7.2m extension to the denture care facility in 2017 to expand tablet compression and packaging capacity.

Speaking today, Site Director at GSK Dungarvan, Brian Fox commented, "This investment from GSK is a significant vote of confidence in the Dungarvan facility, as well as in the capabilities of the town and people of Dungarvan to support such strategic developments. GSK is in Dungarvan 35 years this year and this investment will underpin our existing investments here and our sizeable workforce. It will also significantly enhance Dungarvan’s role in GSK’s global business and today’s investment is a strong recognition of the strong technical and scientific capability we have here."

Source: www.businessworld.ie